Educational seminar at ACMG: Selecting the optimal genetic testing strategy for your patient

Published on February 23, 2017

Blueprint Genetics is taking part in the ACMG Annual Clinical Genetics Meeting on March 22-24, 2017. Join our booth #1031, where we are excited to present our whole test offering and introduce our new methods and services including the one of a kind Connecting Clinicians network. On Friday, March 24, we will hold an educative seminar and discuss the challenges on selecting the optimal genetic testing strategy for your patient.

Join the seminar on Friday, March 24, 2017 at 10:45 at the Phoenix Convention Center, room: Exhibit Theater 2.

ACMG 2017
ACMG Annual Clinical Genetics Meeting, March 22-24, 2017

Learning Objectives:

At the end of this session, participants will be able to:

  • Define the limitations in current genetic testing technologies.
  • Identify the best genetic test in different clinical scenarios.
  • Construct solutions for overcoming limitations in genetic testing.

Tero-Pekka Alastalo, MD, Ph.D, will discuss the challenges presented in selecting genetic testing strategies with case examples used to illustrate how to optimize this process. The current limitations of genetic testing strategies, how to recognize and to overcome them will also be discussed.

 

We also welcome you to check our posters during the conference:

  • Accurate detection of copy number aberrations in inherited disorders using low-coverage whole genome sequencing,
  • Analytic Validation of Oligonucleotide-Selective Sequencing Panels for Clinical Diagnostics of Inherited Disorders

 

Looking forward to seeing you in Phoenix!

News

Blueprint Genetics on valittu vuoden 2017 Kasvunrakentajaksi

Published on March 17, 2017

Vuoden 2017 Kasvunrakentaja on Blueprint Genetics. Suomen pääomasijoitusyhdistys – FVCA:n ja PwC:n yhteistyössä järjestämän Kasvunrakentaja 2017 -kilpailun finaalissa etsittiin pääomasijoittajien yli 700 kohdeyhtiön joukosta mielenkiintoisinta ja innostavinta tarinaa. Suomen pääomasijoitusyhdistyksen ja PwC:n Kasvunrakentaja 2017 -kilpailun voittajaksi valittiin Blueprint Genetics, jonka geenitestausteknologia auttaa löytämään harvinaisia perinnöllisiä tauteja.

Read more